Ocean Biomedical Competitors and Similar CompaniesClear all
Cullgen's competitors and similar companies include Divide & Conquer and Immunochina.
 Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. |  Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. |  Immunochina Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors. | |
Founding Date | Founding Date 2018 | Founding Date 2018 | Founding Date 2015 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ Shanghai, CN Tokyo, JP | Locations Babraham, GB HQ | Locations CN HQ |
Employees | Employees 4 | Employees 2 | Employees 205% increase |
Funding | |||
Latest funding round | Latest funding round $ 16m (about 7 years ago) | Latest funding round $ 12.5m (over 6 years ago) | Latest funding round $ 20.6m (over 7 years ago) |
Total funding raised | Total funding raised $ 31m | Total funding raised $ 12.5m | Total funding raised $ 28.1m |
For sources of this data, please see the company profile
View Company Profiles
Divide & Conquer
HQ
Babraham, GB
Employees
2
Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy.
View companyImmunochina
HQ
CN
Employees
20↑ 5% increase
Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors.
View company